Connect with us

Cannabis News

Tilray expands UK pharmaceutical access through partnerships

Published

4 months ago

on











Tilray Pharma has announced that its European pharmaceutical distribution business, CC Pharma, has entered into an agreement with Smartway Pharmaceuticals to expand the availability of its pharmaceutical products in the UK.

Through this agreement, CC Pharma and Smartway will jointly support the expansion of parallel importation and specialist pharmaceutical supply in the UK, leveraging Smartway’s established national distribution infrastructure to facilitate the delivery of pharmaceutical products and leveraging CC Pharma’s European purchasing power and GMP capability.

The UK pharma market is almost £1 billion in this category, and this agreement positions Tilray and CC Pharma to work with Smartway to accelerate access, improve reliability of supply and extend reach through trusted healthcare channels.

© Tilray Marks

Rajnish Ohri, International President, Tilray Brands, stated, “The UK is a priority market within Tilray’s international medical strategy. This agreement strengthens our ability to expand access to medicines through established healthcare distribution channels, while advancing long-term growth across the evolving European landscape. Additionally, this agreement is expected to integrate Tilray into its medicinal cannabis system.”

Mathias Bossen, Managing Director of CC Pharma added, “This agreement is an important step forward in expanding our pharmaceutical distribution activities in the UK. By working closely with Smartway and leveraging its strong national network, we are well positioned to improve supply reliability and support our pharmacy and hospital partners with high-quality UK PI product lines.”

Josh Cocklin, CEO of Smartway, said: “Our focus is always on patients and outcomes. Extending what Smartway already does in regulated pharmaceutical supply, this deal supports the continuity and expansion of access to medicines across the UK healthcare service. For patients and the healthcare professionals who care for them, this means less disruption and more predictable access to care.”

For more information:
Tilray
www.tilray.com



Publication date:













Related Topics:
Continue Reading

Cannabis News

Judge declines to block New Jersey cannabis Labor Peace Agreement requirement in Curaleaf case

Published

21 hours ago

on

June 23, 2026

By











U.S. District Judge Michael A. Shipp, for the District of New Jersey, ruled against Curaleaf Holdings Inc.’s request for emergency relief to block the requirement that New Jersey cannabis companies sign Labor Peace Agreements (LPAs) to keep the rule in place while the underlying case continues.

Under Bloomberg Law, Judge Shipp issued an unpublished opinion that Curaleaf failed to demonstrate the “irreparable harm” courts require before issuing a preliminary injunction. That rule requires a party to prove that it will later suffer irreparable injury if the judge waits for full proceedings. Judge Shipp concluded that Curaleaf did not meet that threshold.

The resolution is not a decision on the substance of the regulation. Judge Shipp expressed skepticism that the LPA’s requirement is supported under federal law, although he declined to block it. A court may find that a challenger has failed to meet the standard of emergency assistance without adopting the challenged rule.

The New Jersey Cannabis Regulatory Enforcement Assistance and Market Modernization Act, known as CREAMMA, was signed into law by then-governor Phil Murphy in February 2021. It set up a 2020 legalization referendum and established the state’s adult cannabis market. Under CREAMMA, cannabis operators must sign an LPA and engage in collective bargaining with organized labour. These are two different obligations, both licensing requirements, not optional practices.

Curaleaf is opposing this dual mechanism. For New Jersey cannabis operators, the immediate consequence is that compliance remains mandatory while the case moves forward. The question of whether the LPA’s mandate is compatible with federal law remains unanswered.

Source: HeadyNJ



Opening photo: © Curaleaf

Publication date:













Continue Reading

Cannabis News

Maine GOP Lawmaker Gears Up To Fight Anti-Marijuana Ballot Initiative

Published

21 hours ago

on

June 23, 2026

By

“It’s never great politically if your opponent is on TV and you don’t have the money to respond.”

By: Emma Davis, Maine Morning Star

As voters left the Woodfords Club polling station in Portland on June 9, Alex Perez and Hairo Roque, both of Connecticut, asked them to sign one. Mainers petition to roll back recreational use of legalized cannabis a decade ago Similar scenes played out in Poland and other municipalities across the country on election day.

That effort to repeal recreational cannabis was muted after the campaign missed the winter deadline to submit signatures to get it on the November ballot. Now with about 40,000 of the 67,682 signatures needed (at least 10 percent of all votes cast in the last gubernatorial election), the campaign is eyeing the November 2027 ballot, said Caroline Alcock of Massachusetts, the group’s general counsel.

The campaign appears to be driven almost exclusively by out-of-state interests, while local cannabis supporters are organizing in opposition.

“To make a bad poker reference, they’re ‘committed to pot,'” Rep. David Boyer, who led legalization efforts in 2016, said of the campaign’s sole donor, Smart Approaches to Marijuana.

Colin Mack of Brunswick, who is listed as a proponent of the initiative on the secretary of state’s website, told the Maine Morning Star after the election that he thought the effort was over. However, he said that he did not participate, apart from being a local person, to send it to Augusta.

The proposed ballot referendum would ban the commercial cultivation, sale, purchase and manufacture of cannabis starting in 2028, while allowing personal use and possession of up to 2.5 ounces. It would also create new testing and tracking requirements for medical cannabis, which the Maine Legislature rejected earlier this year.

The petition is valid until the spring of 2027, 18 months later, and Alcock said the campaign plans to continue collecting signatures through the summer.

Influence from outside the state

SAM Action, the political arm of Smart Approaches to Marijuana, which funds the campaign, he contributed $2 million in December. As a non-profit, the group is not required to disclose its financial sources.

SAM Action did not respond to multiple requests for comment. (The local Maine affiliate disbanded shortly after the 2016 referendum and is not involved in the current petition, as far as Scott Gagnon knows.)

SAM Action is also the only donor behind a similar anti-cannabis campaign in Massachusetts.

They have been in both Maine and Massachusetts the accusations of some signature collectors that the initiatives are misrepresentedthe leader Maine Secretary of State Shenna Bellows (D) to encourage voters to read the entire petition before signing

Alcock said the campaign’s talking points to collectors are not misleading.

“We think it’s more of an adversarial strategy,” Alcock said of the allegations. “We’re not telling anyone to be misleading to voters or to use anything other than approved and vetted talking points about it.”

Although state law and the Maine Constitution require petition circulators to be Maine residents and registered voters, those residency requirements are largely unenforceable because of federal court rulings.

In 2020, Bellows was sued by a group that argued that the demands protected by the US Constitution’s First Amendment violated “fundamental political speech”.

A district court granted the group — which included We the People PAC, Maine House Minority Leader Billy Bob Faulkingham, a nonprofit and professional signature gatherer — a preliminary injunction, and in 2022, the U.S. Court of Appeals for the First Circuit ruled that the residency requirement was unconstitutional.

The state entered into a consent order with the group, which now follows all Maine citizen initiatives, to allow out-of-state circulators as long as they agree to submit to Maine’s jurisdiction for investigation or prosecution of any alleged violation of Maine law.

Building a defense

Since the re-emergence of an anti-cannabis petition on the ballot, Boyer has begun preparing for the defense.

As the petition began to spread this winter, Boyer opened a bank account and began having initial conversations with local and national groups to organize an opposition campaign.

“I’m going to dust myself off and register with the state and start collecting money,” Boyer said after seeing signature gatherers at the polls earlier this month.

His campaign is not about getting a competitive question on the ballot, but about raising money for “no vote” signs, mailings, TV ads and other ways to oppose the petition.

“We don’t have all the money they need,” Boyer said. “We don’t have to equate one and the other, but you know it’s never good politically if your opponent is on TV and you don’t have the money to respond.”

This story was first published by the Maine Morning Star.

user photo Brian Shamblen.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Ayotte vetoes bill allowing New Hampshire medical cannabis dispensary greenhouses

Published

2 days ago

on

June 22, 2026

By











New Hampshire Governor Kelly Ayotte vetoed Senate Bill 468 on Friday, blocking a bipartisan measure that would have allowed the state’s medical marijuana dispensaries to increase their supply of cannabis and lower prices for patients.

The bill, sponsored by Sen. Howard Pearl, R-Loudon, would limit each dispensary to a single greenhouse for growing its own cannabis. Ayott rejected it outright. In his veto statement, he writes: “I do not support the expansion of marijuana cultivation in our state. That is why I have vetoed SB 468.”

New Hampshire legalized medical marijuana in 2013 under then-governor Maggie Hassan. The state limits possession to two ounces and limits sales to a small network of nonprofit “alternative treatment centers.” The state’s seven dispensaries, located in Chichester, Conway, Dover, Keene, Lebanon, Merrimack and Plymouth, are operated by four such organizations. Patients need a medical marijuana card issued by their doctor to purchase at any of them.

New Hampshire remains the only New England state without legal recreational marijuana. Across the country, 24 states have legalized recreational use and 39 have legalized medical use. Ayotte has previously cited concerns about law enforcement’s inability to measure marijuana-impaired drivers using current technology, as well as the mental health and “quality of life” of young people to oppose broader legalization.

A two-thirds majority in both the House and Senate would be needed to override the veto. Parliament plans to vote on a repeal this year.

Read more at The news










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media